These data highlight that different preparations of MPE and MP diet have multiple pharmacological effects targeting specific and common AD pathologies including: prevention of Aβ production, deposition, and toxicity; inhibition of tau hyperphosphorylation, NMDA excitotoxicity, and AChE activity; and antioxidant and anti-inflammatory activities. The gene discussed is MAPT; the disease is Alzheimer disease.